Granules India informs about press release

14 Jul 2023 Evaluate

Granules India has informed that it enclosed the press release titled ‘Granules India Limited Announced Approval for the Store Brand OTC Equivalent of Advil® Dual Action Tablets’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

585.50 -7.40 (-1.25%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.